Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Michael Y, Sha"'
Autor:
Shuo Shen, Andrew Y. Fu, Maidar Jamba, Jonathan Li, Zhen Cui, Larry Pastor, Daniel Cataldi, Qing Sun, Joseph A. Pathakamuri, Daniel Kuebler, Michael Rohall, Madison Krohn, Daniel Kissinger, Jocelyn Neves, Isaac Archibeque, Aiguo Zhang, Chuanyi M. Lu, Michael Y. Sha
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 11 (2024)
ABSTRACT Given the challenges that SARS-CoV-2 variants have caused in terms of rapid spread and reduced vaccine efficacy, a rapid and cost-effective assay that can detect new and emerging variants is greatly needed worldwide. We have successfully app
Externí odkaz:
https://doaj.org/article/4ec10dc128264475a23af032c1f1b9d2
Autor:
Jinwei Du, Dayu Zhang, Joseph A. Pathakamuri, Daniel Kuebler, Ying Yang, Yulia Loginova, Eric Chu, Roberta Madej, Jocelyn V. Neves, Brianna Singer, Holly Radke, Naomi Spencer, Elizabeth Rizk, Aiguo Zhang, Chuanyi M. Lu, Michael Y. Sha
Publikováno v:
Emerging Microbes and Infections, Vol 11, Iss 1, Pp 250-259 (2022)
Testing and vaccination have been major components of the strategy for combating the ongoing COVID-19 pandemic. In this study, we have developed a quantitative anti-SARS-CoV-2 spike (S1) IgG antibody assay using a fingerstick dried blood sample. We e
Externí odkaz:
https://doaj.org/article/a2a7d7c52c8b40db9c090c72e0755f37
Publikováno v:
Diagnostics, Vol 14, Iss 5, p 488 (2024)
Lung cancer is often triggered by genetic alterations that result in the expression of oncogenic tyrosine kinases. Specifically, ALK, RET, and ROS1 chimeric receptor tyrosine kinases are observed in approximately 5–7%, 1–2%, and 1–2% of NSCLC p
Externí odkaz:
https://doaj.org/article/3d5f8178e89046fbb120a1bb49c0465f
Autor:
Xiaorong Zhou, Chenchen Li, Zhao Zhang, Daniel Y. Li, Jinwei Du, Ping Ding, Haiyan Meng, Hui Xu, Ronglei Li, Effie Ho, Aiguo Zhang, Paul Okunieff, Jianwei Lu, Michael Y. Sha
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Tyrosine kinase inhibitors (TKIs), VEGF/VEGF receptor inhibitors (VEGFIs) and immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced cancers including non-small-cell lung cancer (NSCLC). This study aims to evaluate
Externí odkaz:
https://doaj.org/article/b2343cf2b10446a4ab9c404bea005c66
Autor:
Qing Sun, Jonathan Li, Hui Ren, Larry Pastor, Yulia Loginova, Roberta Madej, Kristopher Taylor, Joseph K Wong, Zhao Zhang, Aiguo Zhang, Chuanyi M Lu, Michael Y Sha
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0243183 (2021)
BackgroundSensitive and high throughput molecular detection assays are essential during the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vast majority of the SARS-CoV-2
Externí odkaz:
https://doaj.org/article/c51f42a3d8e44a04950dc788b5fd6ccc
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0248444 (2021)
The pandemic of novel coronavirus disease COVID-19 is rapidly expanding across the world. A positive result of antibody tests suggests that the individual has potentially been exposed to SARS-CoV-2, thus allowing to identify asymptomatic infections a
Externí odkaz:
https://doaj.org/article/58b2c89659654f9cbb2750140a852922
Autor:
Qing Sun, Larry Pastor, Jinwei Du, Michael J Powell, Aiguo Zhang, Walter Bodmer, Jianzhong Wu, Shu Zheng, Michael Y Sha
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0244332 (2021)
BackgroundColorectal cancer (CRC) is one of the leading causes of cancer-related death. Early detection is critical to reduce CRC morbidity and mortality. In order to meet this need, we developed a molecular clamping assay called the ColoScape TM ass
Externí odkaz:
https://doaj.org/article/6bc54573175a459991b18a9f502219dd
Autor:
Effie Ho, Paul Okunieff, Hui Xu, Michael Y. Sha, Jianwei Lu, Chenchen Li, Xiaorong Zhou, Ping Ding, Daniel Y. Li, Aiguo Zhang, Zhao Zhang, Haiyan Meng, Ronglei Li, Jinwei Du
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports
Scientific Reports
Background: Tyrosine Kinases Inhibitors (TKIs), VEGF/VEGF receptor inhibitors (VEGFIs, bevacizumab) and immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced cancer including non-small-cell lung cancer (NSCLC). Cell-free D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d0523e97cdd57bb61ad5efaf79cb56
https://doaj.org/article/b2343cf2b10446a4ab9c404bea005c66
https://doaj.org/article/b2343cf2b10446a4ab9c404bea005c66
Publikováno v:
Cancer Research. 83:2191-2191
Chromosomal rearrangements resulting in expression of oncogenic chimeric proteins drive tumor progression. Gene fusions are promising targets for cancer therapy in various types of cancers. Therefore, faithful detection of gene fusions is essential i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce2d7c76d1aa91714b8ae7d3c23774a7
https://doi.org/10.1158/1538-7445.am2023-2191
https://doi.org/10.1158/1538-7445.am2023-2191
Autor:
Daniel Kuebler, Dayu Zhang, Hannah May, Joseph Pathakamuri, Michael Y. Sha, Yulia Loginova, Jocelyn V Neves, Aiguo Zhang, Jinwei Du, Eric Chu, Chuanyi M. Lu, Roberta Madej
Among several COVID vaccines that have been approved, the Moderna and Pfizer-BioNTech vaccines are mRNA vaccines that are safe and highly effective at preventing COVID-19 illness. Studies have demonstrated that neutralizing antibody responses elicite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cd1b912d2c38625c48405e38cbf6656
https://doi.org/10.1101/2021.04.11.21255278
https://doi.org/10.1101/2021.04.11.21255278
